SCHEMBL7809704

SCHEMBL7809704

C=CCC1(C2=CCN(C)CC2)c2ccccc2CCc2ccccc21

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
SIGMAR1 Q99720 3/20 0.38
ADRA2A P08913 2/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
MAOA P21397 2/20 0.34
MAOB P27338 2/20 0.34
DRD2 P14416 2/20 0.34
DRD4 P21917 2/20 0.34
DRD1 P21728 1/20 0.34
DRD5 P21918 1/20 0.34
DRD3 P35462 1/20 0.34
SETD7 Q8WTS6 1/20 0.33
CHRM2 P08172 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7817126 0.82 NOTUM (0.40) MAPK1SMN1; SMN2SIGMAR1KMT2A
SCHEMBL7811146 0.82 MAPK1 (0.40) MAPK1SMN1; SMN2SIGMAR1ADRA2AMAOA
SCHEMBL7813352 0.81 SIGMAR1 (0.44) MAPK1SIGMAR1DRD2DRD4DRD3
SCHEMBL7804295 0.74 HTR2A (0.37) SIGMAR1ADRA2AADRA2BADRA2CMAOB
Iodide SCHEMBL7813387 0.73 SIGMAR1 (0.31) SIGMAR1
SCHEMBL10952661 0.65 LMNA (0.49) MAPK1SMN1; SMN2SIGMAR1CHRM2
SCHEMBL29501701 0.65 SIGMAR1 (0.43) SIGMAR1MAOB
SCHEMBL15908347 0.63 SIGMAR1 (0.40) MAPK1SMN1; SMN2SIGMAR1ADRA2AADRA2B
SCHEMBL8506381 0.62 SIGMAR1 (0.38) MAPK1SMN1; SMN2SIGMAR1ADRA2AMAOB
SCHEMBL28922175 0.62 SIGMAR1 (0.41) SIGMAR1MAOBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0733043-B1 TRICYCLIC DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING CORP (US) 2001-06-20 EP disclosed
EP-0733043-A1 TRICYCLIC DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING CORPORATION (US) 1996-09-25 EP disclosed
US-5464840-A Pharmaceuticals to inhibit tumor necrosis factor-alpha and to treat septic shock, inflammation and allergic disease SCHERING CORPORATION (US) 1995-11-07 US disclosed
WO-1995015949-A1 TRICYCLIC DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING CORPORATION (US) 1995-06-15 WO disclosed